Braxia Scientific Corp.
BRAXF · OTC
12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
|---|---|---|---|---|
| Market Cap | $1,502 | $3,580 | $6,250 | $6,807 |
| - Cash | $128 | $710 | $861 | $1,462 |
| + Debt | $637 | $546 | $91 | $207 |
| Enterprise Value | $2,010 | $3,416 | $5,480 | $5,552 |
| Revenue | $492 | $594 | $600 | $522 |
| % Growth | -17.1% | -1% | 14.9% | – |
| Gross Profit | $82 | $5 | -$133 | -$1,005 |
| % Margin | 16.6% | 0.8% | -22.2% | -192.4% |
| EBITDA | -$808 | -$174 | -$742 | -$2,127 |
| % Margin | -164% | -29.2% | -123.6% | -407.1% |
| Net Income | -$907 | -$273 | -$802 | -$7,658 |
| % Margin | -184.2% | -45.9% | -133.7% | -1,465.8% |
| EPS Diluted | -0.003 | -0.001 | -0.003 | -0.029 |
| % Growth | -240% | 66.7% | 89.7% | – |
| Operating Cash Flow | -$533 | -$142 | -$565 | -$1,317 |
| Capital Expenditures | -$9 | $0 | -$2 | -$32 |
| Free Cash Flow | -$542 | -$142 | -$567 | -$1,349 |